Skip to main content
Disease Markers logoLink to Disease Markers
. 2008 Aug 22;25(1):27–35. doi: 10.1155/2008/824640

Molecular Network Analysis of T-Cell Transcriptome Suggests Aberrant Regulation of Gene Expression by NF-κB As a Biomarker for Relapse of Multiple Sclerosis

Jun-ichi Satoh 1,2,*, Tamako Misawa 1, Hiroko Tabunoki 1, Takashi Yamamura 2
PMCID: PMC3827813  PMID: 18776589

Abstract

Molecular mechanisms responsible for acute relapse of multiple sclerosis (MS) remain currently unknown. The aim of this study is to identify the relapse-specific biomarker genes in T lymphocytes of relapsing-remitting MS (RRMS). Total RNA of CD3+ T cells isolated from six RRMS patients taken at the peak of acute relapse and at the point of complete remission was processed for DNA microarray analysis. We identified a set of 43 differentially expressed genes (DEG) between acute relapse and complete remission. By using 43 DEG as a discriminator, hierarchical clustering separated the cluster of relapse from that of remission. The molecular network of 43 DEG investigated by KeyMolnet, a bioinformatics tool for analyzing molecular interaction on the curated knowledge database, showed the most significant relationship with aberrant regulation of gene expression by the nuclear factor-kappa B (NF-κB) in T cells during MS relapse. These results support the logical hypothesis that NF-κB plays a central role in triggering molecular events in T cells responsible for induction of acute relapse of MS, and suggest that aberrant gene regulation by NF-κB on T-cell transcriptome might serve as a molecular biomarker for monitoring the clinical disease activity of MS.

Keywords: KeyMolnet, multiple sclerosis, nuclear factor-kappa B, relapse, T cells

Full Text

The Full Text of this article is available as a PDF (204.2 KB).


Articles from Disease markers are provided here courtesy of Wiley

RESOURCES